8 | Opioid Analgesics (Opioids)IBA
11/2021
-
03/2002 |
7 | Analgesics (Analgesic Drugs)IBA
11/2021
-
05/2008 |
7 | Morphine (MS Contin)FDA LinkGeneric
11/2021
-
09/2003 |
7 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
08/2009
-
06/2002 |
6 | ChemokinesIBA
01/2020
-
05/2008 |
5 | Cannabinoid Receptor AgonistsIBA
05/2008
-
10/2002 |
5 | mu Opioid Receptors (mu Opioid Receptor)IBA
12/2007
-
03/2002 |
4 | Chemokine ReceptorsIBA
11/2021
-
12/2018 |
4 | CannabinoidsIBA
01/2019
-
10/2002 |
4 | LipopolysaccharidesIBA
12/2007
-
03/2002 |
3 | Formaldehyde (Formol)FDA Link
11/2021
-
01/2019 |
3 | Chemokine CXCL12IBA
02/2010
-
05/2008 |
2 | Opioid Receptors (Opioid Receptor)IBA
01/2020
-
02/2007 |
2 | plerixaforFDA Link
12/2018
-
02/2010 |
2 | Stainless Steel (Steel, Stainless)IBA
11/2011
-
04/2011 |
2 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2010
-
05/2008 |
2 | CXCR4 Receptors (CXCR4 Receptor)IBA
02/2010
-
08/2009 |
2 | pyrazoleIBA
03/2007
-
06/2002 |
2 | RimonabantIBA
03/2007
-
06/2002 |
2 | NG-Nitroarginine Methyl Ester (L-NAME)IBA
02/2004
-
10/2002 |
2 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
02/2004
-
10/2002 |
2 | LY 235959IBA
09/2003
-
10/2002 |
2 | Glutamic Acid (Glutamate)FDA Link
09/2003
-
10/2002 |
2 | N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
09/2003
-
10/2002 |
1 | Meperidine (Pethidine)FDA LinkGeneric
06/2019 |
1 | Oxycodone (Oxycontin)FDA LinkGeneric
06/2019 |
1 | CarrageenanIBA
01/2019 |
1 | MaravirocFDA Link
12/2018 |
1 | Antiviral Agents (Antivirals)IBA
01/2015 |
1 | MicroRNAs (MicroRNA)IBA
01/2015 |
1 | Heroin (Diamorphine)IBA
01/2015 |
1 | Buprenorphine (Subutex)FDA LinkGeneric
11/2011 |
1 | Methadone (Dolophine)FDA LinkGeneric
11/2011 |
1 | CXCR ReceptorsIBA
02/2010 |
1 | Glycoproteins (Glycoprotein)IBA
02/2010 |
1 | Proteins (Proteins, Gene)FDA Link
02/2010 |
1 | Dopamine AntagonistsIBA
10/2008 |
1 | SCH 23390IBA
10/2008 |
1 | Dopamine (Intropin)FDA LinkGeneric
10/2008 |
1 | N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
10/2008 |
1 | Chemokine CCL5IBA
09/2008 |
1 | AntibodiesIBA
09/2008 |
1 | CXC ChemokinesIBA
05/2008 |
1 | SR 144528IBA
03/2007 |
1 | CB2 Cannabinoid ReceptorIBA
03/2007 |
1 | CB1 Cannabinoid Receptor (CB1 Receptor)IBA
03/2007 |
1 | kappa Opioid Receptors (kappa Opioid Receptor)IBA
12/2005 |
1 | Ala(2)- deltorphin IIIBA
09/2004 |
1 | Mesylates (Mesylate)IBA
02/2004 |
1 | Drug CombinationsIBA
02/2004 |
1 | Nitric Oxide Synthase (NO Synthase)IBA
02/2004 |
1 | Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA
09/2003 |
1 | Cocaine (Cocaine HCl)IBA
11/2002 |
1 | N- (2- (3,4- Dichlorphenyl)ethyl)- N,N',N'- trimethyl- 1,2- ethandiaminIBA
11/2002 |
1 | ethylamineIBA
11/2002 |
1 | N-Methylaspartate (NMDA)IBA
10/2002 |
1 | Dextromethorphan (Racemethorphan)FDA LinkGeneric
10/2002 |
1 | isoquinolineIBA
10/2002 |
1 | (trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA
10/2002 |
1 | Interleukin-1beta (Interleukin 1 beta)IBA
03/2002 |
1 | Interleukin-6 (Interleukin 6)IBA
03/2002 |
1 | PyrogensIBA
03/2002 |